Correlation Between Omeros and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Omeros and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Omeros and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Omeros and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Omeros and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Omeros with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Omeros and Crinetics Pharmaceuticals.
Diversification Opportunities for Omeros and Crinetics Pharmaceuticals
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Omeros and Crinetics is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Omeros and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Omeros is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Omeros are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Omeros i.e., Omeros and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Omeros and Crinetics Pharmaceuticals
Given the investment horizon of 90 days Omeros is expected to generate 1.27 times more return on investment than Crinetics Pharmaceuticals. However, Omeros is 1.27 times more volatile than Crinetics Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about -0.15 per unit of risk. If you would invest 974.00 in Omeros on December 28, 2024 and sell it today you would lose (127.00) from holding Omeros or give up 13.04% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Omeros vs. Crinetics Pharmaceuticals
Performance |
Timeline |
Omeros |
Crinetics Pharmaceuticals |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Omeros and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Omeros and Crinetics Pharmaceuticals
The main advantage of trading using opposite Omeros and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Omeros position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.Omeros vs. Enanta Pharmaceuticals | Omeros vs. Amicus Therapeutics | Omeros vs. Connect Biopharma Holdings | Omeros vs. Ligand Pharmaceuticals Incorporated |
Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Passage Bio | Crinetics Pharmaceuticals vs. Regenxbio | Crinetics Pharmaceuticals vs. Kezar Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |